Mackay Shields LLC Aquestive Therapeutics, Inc. Transaction History
Mackay Shields LLC
- $514 Million
- Q1 2025
Shares
2 transactions
Others Institutions Holding AQST
# of Institutions
130Shares Held
47.1MCall Options Held
44.6KPut Options Held
182K-
Bratton Capital Management, L.P. Fort Worth, TX9.81MShares$28.8 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.45MShares$16 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.07MShares$12 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY3.73MShares$11 Million0.45% of portfolio
-
Geode Capital Management, LLC Boston, MA1.7MShares$5 Million0.0% of portfolio
About Aquestive Therapeutics, Inc.
- Ticker AQST
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,350,700
- Market Cap $157M
- Description
- Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...